ACADIA Pharmaceuticals, Inc. (ACAD)
27.26
-0.36
(-1.30%)
USD |
NASDAQ |
Dec 29, 16:00
27.26
0.00 (0.00%)
After-Hours: 20:00
ACADIA Pharmaceuticals Market Cap: 4.612B for Dec. 29, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Aldeyra Therapeutics, Inc. | 311.04M |
| Vanda Pharmaceuticals, Inc. | 425.50M |
| ADMA Biologics, Inc. | 4.548B |
| Amicus Therapeutics, Inc. | 4.397B |
| ANI Pharmaceuticals, Inc. | 1.828B |
Market Cap Related Metrics
| PE Ratio | 17.54 |
| PS Ratio | 4.385 |
| PEG Ratio | 0.1733 |
| Price to Book Value | 5.028 |
| Price to Free Cash Flow | 46.39 |
| Price | 27.26 |
| Earnings Yield | 5.70% |
| PEGY Ratio | 0.1733 |
| Operating PE Ratio | 48.63 |
| Normalized PE Ratio | 17.54 |